Discovering a Common Goal,
Discovering a Cure


Research News
Drug News
Conference News
< Home

Denali Appoints Carole Ho as Chief Medical Officer
July 23, 2015

South San Francisco-based Denali Therapeutics has appointed physician-scientist and industry leader Carole Ho as Chief Medical Offer and Head of Development. The company was launched earlier...

Aquinnah Pharmaceuticals to Advance Development of TDP-43-Targeting Compounds
July 23, 2015

Aquinnah Pharmaceuticals is a new start-up company in the neurodegenerative disease space launched last year on the foundation of research from the laboratory of Benjamin Wolozin at Boston University....

ALSA Awards $11.6 Million in Grants for Research, Biomarkers, Drug Development and Clinical Trials
July 23, 2015

The ALS Association has announced 58 new research grants totaling $11.6M to fund research into genetics of ALS, new disease models, biomarkers, drug development and clinical trials. The list of grants provides an overview of exciting and cutting...

Cytokinetics Begins Phase III Trial of Tirasemtiv in ALS
July 14, 2015

The California-based biopharmaceutical company Cytokinetics has announced the initiation of a Phase III clinical trial of its drug tirasemtiv in ALS.  The drug, a small molecule troponin activator,...

Multi-institutional French and UK Collaboration to Initiate Clinical Trial of IL-2 in ALS
July 9, 2015

An ambitious, multi-institutional clinical trial of low dose interleukin-2 (IL-2) in ALS has received funding from Motor Neuron Disease Association in the UK, the French government and the European Commission’s

The ALS Forum was developed by Prize4Life, Inc.
© 2015 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum